Rhode Island Hospital, 55 Claverick St., 2nd floor, Providence, RI 02903, USA.
J Am Pharm Assoc (2003). 2013 May-Jun;53(3):273-81. doi: 10.1331/JAPhA.2013.12094.
To assess differences in prescription monitoring program (PMP) use between two states with different PMP accessibility (Connecticut [CT] and Rhode Island [RI]), to explore use of PMPs in pharmacy practice, and to examine associations between PMP use and pharmacists' responses to suspected diversion or "doctor shopping."
Descriptive nonexperimental study.
CT and RI from March through August 2011.
Licensed pharmacists in CT and RI.
Anonymous surveys e-mailed to pharmacists
PMP use, use of patient reports in pharmacy practice, and responses to suspected doctor shopping or diversion.
Responses from 294 pharmacists were received (CT: 198; RI: 96). PMP users were more likely to use the PMP to detect drug abuse (CT: 79%; RI: 21.9%; P < 0.01) and doctor shopping (67%; 7%; P < 0.01). When faced with suspicious medication use behavior, PMP users were less likely than nonusers to discuss their concerns with the patient (adjusted odds ratio 0.48 [95% CI 0.25-0.92]) but as likely to contact the provider (0.86 [0.21-3.47]), refer the patient back to the prescriber (1.50 [0.79-2.86]), and refuse to fill the prescription (0.63 [0.30-1.30]). PMP users were less likely to state they were out of stock of the drug (0.27 [0.12-0.60]) compared with nonusers. Pharmacists reported high interest in attending continuing education on safe dispensing (72.8%).
Pharmacists are important participants in the effort to address prescription drug misuse and abuse. Current PMP use with prevailing systems had limited influence on pharmacy practice. Findings point to future research and needed practice and education innovations to improve patient safety and safer opioid dispensing for pharmacists.
评估两个州(康涅狄格州[CT]和罗得岛州[RI])在处方监测计划(PMP)使用方面的差异,探讨 PMP 在药房实践中的使用情况,并检验 PMP 使用与药师对疑似药物滥用或“医生购物”的反应之间的关联。
描述性非实验性研究。
2011 年 3 月至 8 月的 CT 和 RI。
康涅狄格州和罗得岛州的持照药剂师。
向药剂师发送匿名调查电子邮件。
PMP 使用情况、在药房实践中使用患者报告情况,以及对疑似医生购物或药物滥用的反应。
收到了 294 名药剂师的回复(CT:198;RI:96)。PMP 用户更有可能使用 PMP 来检测药物滥用(CT:79%;RI:21.9%;P<0.01)和医生购物(67%;7%;P<0.01)。当面临可疑的用药行为时,PMP 用户比非用户更不可能与患者讨论他们的担忧(调整后的优势比 0.48[95%CI 0.25-0.92]),但同样可能与提供者联系(0.86[0.21-3.47])、将患者转介给开处方者(1.50[0.79-2.86]),以及拒绝配药(0.63[0.30-1.30])。与非用户相比,PMP 用户表示药品缺货的可能性较小(0.27[0.12-0.60])。药剂师报告对参加安全配药继续教育有浓厚兴趣(72.8%)。
药剂师是解决处方药物滥用问题的重要参与者。当前 PMP 的使用与现行系统结合,对药房实践的影响有限。研究结果表明,需要进行未来研究和必要的实践与教育创新,以提高患者安全和药剂师更安全地配药阿片类药物。